BC-CfE Interim Recommendations for COVID-19 and Persons with HIV
Recommendations for the prevention, diagnosis, management and treatment of COVID-19 in people with HIV are the same as those for the general population [1]. The available data about the incidence and course of COVID-19 disease in persons with HIV continues to evolve. However, some people with HIV have comorbidities (e.g., cardiovascular disease, lung disease, diabetes mellitus, obesity) that are known to be associated with an increased risk of more severe COVID-19 illness.
Read More
BC-CfE CDET Statement on the use of COVID-19 vaccines in Persons Living with HIV
People living with HIV (PLWH) aged 18 years or older should be vaccinated for COVID-19 if they meet current Public Health criteria for priority groups and if they have no contraindications (see below). These vaccines are not expected to be associated with more serious or different adverse events among PLWH or other immunocompromised individuals.
Read More
BC-CfE studies immune response to COVID-19 vaccines among the elderlyBLOGRead more21-SEP-2021
Updated Primary Care Guidelines for the Management of HIV/AIDSTherapeutic GuidelinesView GuidelinesSeptember 20, 2021
BC-CfE Researchers help fight drug resistance to Hepatitis C treatmentsBLOGRead more16-SEP-2021
BC-CfE’s Dr. Robert Hogg elected as a Fellow of the Royal Society of CanadanBLOGRead more13-SEP-2021
Emergent global pandemic threats: origin, spread, and adaptation of sars-cov-2Education & TrainingRegisterSeptember 22, 2021
New Educational Webinar:
Blog postBC-CfE researchers examine mood and anxiety disorders and their links to HIV risk among sexual minoritiesRead more
